DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Chowdary P, Lethagen S, Friedrich U. , et al.
Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial.
J Thromb Haemost 2015;
13 (05) 743-754
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.